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Abstract
Background: WHO-ILAR COPCORD Program is a 
program that aimed to obtain data on joints pain and 
musculoskeletal diseases in developing countries, 
one aspect which has not been studied is the ability 
of COPCORD questionnaire as a screening tool 
which standardized for  screening  joint pain and 
musculoskeletal diseases. Objective of this study is to 
assess the validity of modified COPCORD questionnaire 
Indonesian version in screening joint pain and 
musculoskeletal disease compared to examination by 
rheumatologists.
Method: The initial phase of the research is determining 
essential points, translation to Indonesian, and back 
translation. The second stage is testing questionnaires 
in communities which 100 respondents involved. 
Dependent variable is the diagnosis of rheumatic 
diseases and independent variables are pain in less 
and more than 7 days, high degree pain in less and 
more than 7 days, history of NSAIDs/Steroids/DMARDs 
use, and disabilities. Validation test was assessed by 
calculating the sensitivity, specificity, PPV, NPV, LR+, 
and ROC curve. Bivariate analysis using Chi Square 
analysis, and multivariate analysis using logistic 
regression.
Result: The sensitivity test results is best obtained on 
the question history of NSAIDs/steroids/DMARDs use 
(100%)  and specificity is best obtained on the question 
about disability (98%). ROC curve analysis which the 
results >85% obtained on the question of pain >7 days 
(90%), high degree pain >7 days (93%), and history of 
NSAIDs/steroids/DMARDs use (92%).  LR+ to diagnose 
rheumatic diseases found in all questions. Chi square 
analysis showed that all questions were significant with 
p <0.05 and odds ratio (OR) obtained most on high 
degree pain more than 7 days (OR: 180.167; 95% CI: 
38.196-849.834). 
Conclusion: The modified COPCORD questionnaire 
Indonesian version has been adapted and can be a good 
tool in the screening of joint pain and musculoskeletal 
diseases compared to examination by rheumatologists.
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Introduction
Joint pain and musculoskeletal disease is the most 
common cause of morbidity in general population. 
Even rheumatic diseases not increase mortality 
but it can lead to disabilities and low quality of 
life and productivity.1 On the other hand the need 
of data on the magnitude of the problem and the 
effects of joint and musculoskeletal diseases is very 
important, especially in developing countries such 
as Indonesia. Based on these data we can see the 
effect of the disease and provide recommendation 
and intervention plan both in terms of detection and 
therapy.2
In the 1981 the International League against 
Rheumatism (ILAR) and the World Health 
Organization (WHO) jointly launched the WHO-
ILAR Community Oriented Program for the Control 
of Rheumatic Diseases (COPCORD) to obtain 
data on the joints and musculoskeletal diseases in 
developing countries. COPCORD is a low cost 
program which requires minimal infrastructure 
by relying on existing resources. Using the same 
and validated method, COPCORD Phase 1 ( out of 
3 phase) has been succeeded to collect data from 
Australia,3 Bangladesh,4 Brazil,5 Chile,5 China,6 
Cuba,7 Egypt,8 Guatemala,9 India,10 Indonesia,11 
Iran,12 Kuwait,13 Malaysia,14 Mexico,5, 15 Pakistan,16 
Philippines,17 Thailand,18 Taiwan,19 Tunisia20 and 
Vietnam.10, 21-23
One aspect of COPCORD which has not been 
studied is the ability COPCORD questionnaire as 
a screening tool that is standardized in rheumatic 
diseases. For population who has limited health 
facility level or limited time and resources, 
this questionnaire would be more suited to be 
applied in a broad population. The consideration 
of COPCORD as a standardized tool, requires 
validation of certain aspects like diagnostic tests, 
especially when compared to complete examination 
conducted by rheumatologist.24, 25 In the other hand, 
the adaptation and translation into Indonesian 
questionnaire also have consequences in language 
and cultural adaptation that may be different from 
the original.26 Based on this fact, it is necessary 
to validate a modified COPCORD questionnaire 
Indonesian version for screening of joint pain and 
musculoskeletal diseases in Malang.
The aim of this study is to assess the validity 
of modified COPCORD questionnaire Indonesian 
version, for screening joint pain and musculoskeletal 
disease in the population compare to examination 
done by rheumatologist.
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Method
This research was an analytic study using cross sectional 
approach, involving 100 respondents consist of Malang’s 
residents. Inclusion criteria for this study are all people aged 
over 15 years and exclusion criteria are respondents who are 
unwilling or unable to be interviewed and examined.
The dependent variable in this study was the diagnosis of 
rheumatic disease, while independent variables were based 
on the core of the questions in the COPCORD questionnaire 
which are, the pain are less than 7 days and more than 7 days, 
high degree pain of less than 7 days and more than 7 days, 
history of NSAIDs/Steroids/DMARD use, and disabilities. 
Descriptive statistics in this study were sensitivity, specificity, 
positive predictive value, negative predictive value, positive 
likelihood ratio and the ROC curve of each question to the 
diagnosis of rheumatic disease. This questionnaire is valid 
if sensitivity and specificity >80%, LR+ >1 and ROC curve 
are more than 0.8.27 Chi square analysis method was used 
to analyze association between two categorical variables. 
Furthermore, multivariate analysis of the significant variables 
was done by logistic regression. The analysis was performed 
with SPSS software version 22.The workflow in this study 
displayed on picture 1:
Picture 1. Workflow of Validating COPCORD Questionnaire
This study conducted in two stage, are stage 1 is an adaptation 
of COPCORD questionnaire, including:
a. Determine important points in COPCORD questionnaire 
In this step, agreement was made on some important 
points such as pain, degree of pain, therapies which have 
been obtained and the impact of rheumatic diseases on 
disability. Questions about ethnicity and religion were 
eliminated because the population is homogeneous and 
researchers believe that religion is not associated with joint 
pain and musculoskeletal disease. In addition, the question 
about the activity index is adapted from questionnaires 
GPPAQ28.
b. Translating COPCORD quesionnaire into Bahasa 
Indonesia 
The next step was the translation of modified COPCORD 
questionnaire into Bahasa Indonesia. The translation 
process was carried out by researchers in join discussions 
with rheumatologist. Addition of question about physical 
activity which adapted from GPPAQ in to questionnaire 
was agreed by researchers. 28 Then, questionnaire was 
translated back into English by using a third party service 
from English Language Laboratory, Faculty of Medicine, 
Brawijaya University.
c. Questionnaire trial and researchers agreement
After obtaining a good translation of the COPCORD 
questionnaire into Bahasa Indonesia and evaluation on the 
back translation, trials conducted on questionnaires with 
fellow researchers and research agreements. From the test 
results of this questionnaire show that the words of the 
questionnaire can be well-received and found interview 
duration about 30 minutes so researchers can estimate time 
on the field. 
On the stage-2, the community validation study was 
performed to evaluate the usefulness of modified COPCORD 
questionnaire Indonesia version to detect joint pain and 
musculoskeletal diseases compared to physical examination 
performed by rheumatologists. In this way the sensitivity and 
specificity of the questionnaire COPCORD compared with 
clinical diagnosis can be seen and whether the instrument 
is a good screening tool for joint pain and musculoskeletal 
diseases in the community.
In this research there was also reliability study to assess 
internal concistency with cronbach alpha and test retest 
method  analyzed with intraclass correlation coefficient (ICC). 
Test retest method in this study was done by asking the same 
questionnaire to 15 random participants twice within 4 weeks 
interval. ICC value ranged from 0 until 1 and interpreted as 
follow: 0−0.2 indicate poor agreement: 0.3−0.4 indicate fair 
agreement; 0.5−0.6 indicate moderate agreement; 0.7−0.8 
indicate strong agreement; and >0.8 indicate almost perfect 
agreement.29
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Result 
Sample Baseline Characteristics 
In this research we include 100 respondents in our study. 
Sample baseline characteristics in this study can be seen in 
table 1.
Table 1. Sample Baseline Characteristics
Characteristics Percentage N = 100
Rheumatic Disease
Yes 50 
No 50
Pain < 7 hari
Yes 39 
No 61 
Pain >7 hari
Yes 52 
No 48 
High degree pain <7 hari (VAS >4/10)
Yes 15 
No 85 
High degree pain >7 hari (VAS >4/10)
Yes 49 
No 51 
History of NSAID/Steroid/DMARD use
Yes 58 
No 42 
Disability
Yes 16 
No 84 
Validation of COPCORD Questionnaire for the screening of Joint Pain and 
Musculoskeletal Disease
Validation study in the community, the aim is to see 
questions’ sensitivity and specificity, are: the presence of 
pain, degree of pain, medication history, and disability. By 
doing this way we can see the sensitivity and specificity of 
the modified COPCORD questionnaire Indonesian version 
compared to clinical diagnosis and investigate whether the 
instrument is can be used as a good screening tool for joint 
pain and musculoskeletal diseases in the community.
We present the results of our analysis in the form of 
sensitivity, specificity, positive predictive value, negative 
predictive value, likelihood ratio positive (LR +), and the 
ROC curve (area under the receiver operating characteristic 
curve) on how the questions in the COPCORD questionnaire 
can predict clinical evaluation of rheumatic diseases can be 
seen in table 2. The highest results of the sensitivity among 
others are on the question about history of pain over 7 days 
(92%), high degree pain (pain with VAS> 4/10) at pain over 
7 days (92%), and history of NSAIDs/steroids/DMARDs use 
(100%). While the highest specificity obtained on question 
about high degree pain on pain of less than 7 days (96%), a 
high degree of pain on pain of more than 7 days (94%) and the 
disability (98%).
Table 2. Diagnostic Test of COPCORD Questionnaire Points 
against Rheumatic Disease Diagnosis
COPCORD
Questions
Rheumatic Disease Diagnosis (n = 100)
Sensitivity 
(%)
Specificity 
(%)
PPV
(%)
NPV
(%)
LR
(+) ROC
Pain < 7 days 64 86 82 70 6.25 0.75
Pain >7 days 92 88 88 92 4.57 0.90
High degree pain 
<7 days
26 96 87 56 7.67 0.61
High degree pain 
>7 days
92 94 94 92 6.5 0.93
History of 
NSAID/Steroid/
DMARD use
100 84 86 100 15.3 0.92
Disability 30 98 94 58 15 0.64
High degree pain: pain with visual analog scale >4/10, 
NSAID: Non Steroidal Anti Inflammatory Drug, DMARD: 
Disease Modifying Anti Rheumatoid Drug, LR (+): Positive 
Likelihood Ratio, ROC: area under the receiver operating 
characteristic curve
Picture 1. ROC Curve of COPCORD Questionnaire Points 
against Rheumatic Disease Diagnosis
ROC curve analysis with the results >85% obtained on 
the question of pain >7 days (90%), high degree pain >7 days 
(93%), history of NSAIDs/Steroids/DMARDs use (92%) 
showed a strong predictive value against rheumatic diseases 
diagnosis.
Additionally, LR+ >1 to the diagnosis of rheumatic disease 
was found in all the questions, pain in less than 7 days, history 
of pain more than 7 days, high degree pain of less than 7 days, 
history of high degree pain of more than 7 days, history of 
NSAIDs/steroids/DMARDs use and disability according 
to MHAQ. These variables were analyzed using chi square 
analysis showed that all the questions were significance with 
p <0.05 with odds ratio (OR) obtained at the most from history 
of high degree pain (VAS >4) more than 7 days, OR = 180.167 
(95% CI 38.196−849.834). The results of bivariate analysis 
can be seen on table 3.
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Multivariate analysis on the questions carried out 
simultaneously by logistic regression do not  show significant 
results. 
Table 3. Analysis of Each COPCORD Questionnaire Points
against Rheumatic Disease Diagnosis
COPCORD Questions p OR 95% CI
Pain < 7 days <0.001 10.921 4.075−29.263
Pain >7 days <0.001 84.333 22.283−319.171
High degree pain <7 days 0.002 8.432 1.791−39.698
High degree pain >7 days <0.001 180.167 38.196−849.834
History of NSAID/Steroid/ 
DMARD use <0.001 - -
Disability <0.001 21.000 2.649−166.454
High degree pain: pain with visual analog scale >4/10, 
NSAID: Non Steroidal Anti Inflammatory Drug, DMARD: 
Disease Modifying Anti Rheumatoid Drug, OR: Odd Ratio, 
CI: Confidence Interval
The reliability study showed that cronbach alpha analysis 
is good in all question with coefficient ranged from 0.737 
until 1.000. While analysis with ICC the result ranged from 
0.754 until 1.000. The results of reliability study can be seen 
on table 4.
Tabel 4. Reliability Study of Each  COPCORD 
Questionnaire Points
COPCORD Questions Cronbach Alpha ICC p
Pain < 7 days 0.756 0.767 0.004
Pain >7 days 0.737 0.754 0.005
High degree pain <7 days 0.772 0.754 0.005
High degree pain >7 days 0.822 0.808 0.001
History of NSAID/Steroid/ 
DMARD use
1.000 1.000 <0.001
Disability 0.737 0.754 0.005
ICC: Intraclass Correlation Coefficient
Discussion
Questionnaire as a tool is already frequently used in medical 
research. By the increasing number of multinational 
and multicultural research, the need of adaptation to the 
questionnaire which has been used in languages  other than 
English also growing rapidly because most of the questionnaire 
are in English.30 The need of adaptation to the language and 
culture become important in Asia-Pacific because of the need 
of data on rheumatic diseases. Hopefully the questionnaire 
will produce a study about the identification of risk factors 
and at the same time it will ensure the uniformity of data, and 
if collected, could be identification of risk factors with high 
quality and precision. Generally, most of questionnaires were 
made in English but only a few population who uses English 
as daily language. Therefore, there was a necessary to adapt 
questionnaires into local language and culture.31
This study was conducted to determine the ability of 
modified COPCORD questionnaire Indonesian version as 
a screening tool for rheumatic diseases. The questionnaire 
was validated and applied as a screening tool to detect 
musculoskeletal disorders in the community, especially in 
developing countries like Indonesia.Until now its ability to 
identify patients with joint pain and musculoskeletal disease 
still need further investigation, especially in Indonesia. 
However, a similar study has been done in other COPCORD 
research6, 32, 33
In this study, the adaptation is done by selecting the 
important points which are already covered in the questionnaire 
COPCORD that has been validated in multiple languages 
before. Selection of these points affect to the removal of 
questions on ethnicity and religion, it because religion does 
not affect the joints pain and musculoskeletal diseases.34 
Although ethnicity play an important role in the incidence of 
some joints and muskuloskeletal diseases ,34 there is no ethnic 
differences in people of Malang.
Besides, the modifications were  made by addition question 
about physical activity which adapted from questionnaires 
GPPAQ used by the health department in the UK,34 The 
additional questioncan also be used to measure the level of 
daily activity, so we can see if there a relationship between 
the activities of a person with the incidence of joint pain and 
musculoskeletal diseases. In the UK, the questionnaire is used 
to assess person’s activity level, so it can give some advice to 
person to act an active lifestyle to avoid the various chronic 
and metabolic diseases caused by inactive lifestyle35.
The key points are selected in this analysis include pain in 
less than 7 days and more than 7 days, high degree pain in less 
than 7 days and more than 7 days, history of NSAIDs/Steroids/
DMARDs use, and disabilities. It based on the definition 
of joint pain and musculoskeletal diseases are collection of 
symptoms include joint pain, swelling and/or limitation of 
motion. Therefore by asking if any joint pain in the form of 
signs of joint pain, and/or soft tissue/musculoskeletal pain, 
and/or joint swelling, and/or stiffness of the joints and/or 
stiffness in the spine, and/or reduced movement on any joint 
and/or reduced movement in spine or neck are expected to see 
their joint pain and musculoskeletal diseases then it would be 
confirmed by physical examination. 
Adding a category about high degree of pain is based on 
the results of a previous study by Bennett, et al which was 
cross-cultural adaptation and validation of the questionnaire 
COPCORD in Mexico, originally the sensitivity and specificity 
of the questionnaire COPCORD was 84% and 61.3%, but by 
adding a category based on VAS pain score >4, the sensitivity 
decreased to 42.7% and the specificity increased to 80%, 36 
so the researchers decided to use both components of the 
pain question. In this study, variable about duration of pain 
and high degree of pain have high sensitivity and specificity 
(Pain <7 days: sensitivity 64%, specificity 86%; Pain >7 days: 
sensitivity 92%, specificity 88%; High degree of pain <7 days: 
sensitivity 26 %, specificity 96%; High degree of pain > 7 
days: sensitivity 92%, specificity 94%). It indicates that the 
questionnaire can be a good screening tool for joint pain and 
musculoskeletal diseases.
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Questions about the use of medicines such as NSAIDs, 
DMARDs and steroids also affect the diagnosis of joint and 
musculoskeletal disease which in patients with joint pain and 
musculoskeletal disease pain are the main complaint so that 
patients will seek treatment to relief the pain either by self 
treatment or by going to the doctor, and the treatment carried 
out in the short term or long term, depending on the patient’s 
perceived pain. Usually patients who have been diagnosed 
with joints and musculoskeletal diseases will get treatment 
from doctors such as  pain killer or other drugs to slow or 
halt the disease process such as steroids or DMARD.37 The 
variable about  history of drug use whether NSAIDs, steroids 
and DMARD has sensitivity 100% and specificity of 84%. 
It indicates that all respondents who have diagnosed joint 
disease and musculoskeletal disease, not all of them take 
drugs in accordance with indication.
Questions about disability in this study was adapted 
from MHAQ questionnaires, which has relationship between 
disability and joint pain and musculoskeletal disease.38 In this 
study, obtained with a sensitivity 30% and specificity 98%, 
illustrating that the question is specific but not sensitive to patients 
with a diagnosis of joint pain and musculoskeletal disease.
After determining the important points, translation and 
back translation was done by linguists to ensure that no 
significant changes during the translation process that will 
change the meaning or intent of the questions.
COPCORD modified questionnaire in this study can serve 
as a tool to measure magnitude of the epidemiology of joint 
pain and musculoskeletal disease and also to assess the risk 
factors that influences to the diseases. This questionnaireis 
expected not only can be used by clinicians as a screening tool 
for joint pain and musculoskeletal disease, but also applicable 
for other health professionals such as paramedics.
In a population study at Mexico by Robles, et al there are 
four variables which have good performance in diagnostic tests 
are: pain in the past 7 days, the high degree of pain, history of 
treatment with NSAIDs, and earlier diagnosis. However, these 
results vary in certain diseases, such as in Osteoarthritis (OA).. 
Most of significant question of OA is a pain in the last 7 days, 
HAQ score, and earlier diagnosis; for Rheumatic Regional 
Pain Syndrome (RRPS), just a pain in the last 7 days; and for 
Rheumatoid Arthritis (RA) (in addition to the 4 questions) are 
history of pain without trauma, use of NSAIDs, HAQ score, 
and physical limitations are reported all correlated with the 
diagnosis. In addition, it is estimated that the questions that 
have LR + ≥ 2, showed a clear correlation with the diagnosis of 
arthritis which can be applied at population. 25 Another study in 
the Philippines by Dans, et al found that the sensitivity of the 
COPCORD questionnaire was 91% (95% CI, 85−95) while 
the specificity was 51% (95% CI, 43−59).39 This association 
indicates that the questionnaire could be implemented as part 
of the referral process, start from primary care to specialist 
care. It is because important considerations should be noted 
in the screening test addition is the questions not only having 
adequate sensitivity but also it has high specificity.
The questionnaire in this study meet these requirements, 
which some variables have good sensitivity such as the history 
of pain over 7 days (92%),  high degree of pain (pain with 
VAS> 4/10) at pains over 7 days (92%), and history of drug 
use (NSAIDs/dsteroid/DMARD) (100%) and specificity of 
the question : high degree of  pain which less than 7 days 
(96%), high degree of pain which more than 7 days (94%) 
and the presence of disability ( 98%), makes the questionnaire 
is more specific than sensitive.The result of reliability study 
with cronbach alpha dan ICC in this study showed good result 
with coefficient of Cronbach alpha ranged from 0.737 until 
1.000. While ICC analysis results ranged from 0.754 until 
1.000. Landis and Koch29 stated that value 0.7−0.8 indicates 
strong agreement; and value >0.8 indicates almost perfect 
agreement this result showed that the questionnaire is reliable 
in diagnosis of joint pain and musculoskeletal diseases.
The benefits of COPCORD questionnaire can detect 
a common rheumatic disease which can help patients to 
promptly diagnosed and treated by rheumatologists. It is 
becoming an alternative in developing countries where health 
systems are still not well organized like in Indonesia. Moreover 
in the first-level health facilities, efficient guides for detecting 
rare cases and health facilities are still inadequate. This 
questionnaire method in the first-level health facility is needed 
to be introduced for screening rheumatic disease. Woolf, et al 
wrote a persuasive article about prevention of musculoskeletal 
diseases , especially in developing countries40, and give a 
number of recommendations, such as: (1) effective prevention 
and control against musculoskeletal diseases as a priority, 
(2)  increasing public and individual awareness about issues 
which relate to musculoskeletal disease such as spreading a 
good quality information, (3) and the need of early diagnosis 
the musculoskeletal disease.
The advantages of this questionnaire is easy to carry out 
the screening process because it requires minimal resources, 
so that it can reach all health professionals, especially in 
developing countries like in Indonesia. Therefore we can obtain 
epidemiological data that would support  health planning 
system and as an initial screening for diagnosis of joint pain 
and musculoskeletal diseases in the wider community.
But the obstacles that may be encountered is the 
questionnaire consist of many questions which could be make 
the respondent and interviewer feel bored or uncooperative 
during the interview process. It can be repaired with practice 
regularly, so the interviewer can ask nicely without makes 
respondents feel bored and cooperative during the interview 
process.
Conclusion
Modified COPCORD Questionnaire to Indonesian Version 
has been adapted and can be  asa good tool in screening 
and detection of joint pain and musculoskeletal diseases, 
especially in Indonesia. This questionnaire has good 
sensitivity and specificity, so it can be a valid and effective 
tool for screening  joint pain and musculoskeletal diseases 
compared to examination by rheumatologists 
The authors suggest for the application of a modified 
version of the questionnaire COPCORD Indonesian in 
epidemiological studies especially on basic health facilities 
as a first step in screening for joint pain and musculoskeletal 
diseases in Indonesian society.
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